Oct 23rd, 2024
Sunday's Featured Science
Don't miss these studies of HFpEF treatments.
FS.03 | Featured Science: Getting Closer to the Summit: New HFpEF Treatments
Sunday, Nov. 17 | 8:00–9:15 a.m. | S100A
Heart Failure and Cardiomyopathies
- Effect of Finerenone on a Hierarchical Composite Endpoint Analyzed Using Win Statistics in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF
- Efficacy and Safety of Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Sex-Specific Analysis of the FINEARTS-HF Trial
- Finerenone and Risk of Hyperkalemia in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF)
- Effects of Tirzepatide on Cardiorenal End-Organ Damage in Heart Failure and Preserved Ejection Fraction: Insights From the SUMMIT Trial
